Clinical Trial Update: R33: Levetiracetam in Early Psychosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating levetiracetam for early psychosis has completed. The provided snippet does not include the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis

Drugs mentioned

• Levetiracetam (Keppra) (levetiracetam)

Snippet

Sponsor: NYU Langone Health | Conditions: Early Psychosis | Phase 2 | Status: COMPLETED